Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1Disease Progression 1

Interventions

Lenalidomide 4Dexamethasone 4Bortezomib 3pomalidomide 2Cyclophosphamide 2ricolinostat 1Zoledronic Acid 1Vitamin D 1Transplantation, Autologous 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Calcium Dobesilate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Vitamin D × Plasma cell × Clear all
NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated
143 enrolled 10 charts
Plasma cell

Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡